Correlation Between Payment Financial and Clal Biotechnology

Can any of the company-specific risk be diversified away by investing in both Payment Financial and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Payment Financial and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Payment Financial Technologies and Clal Biotechnology Industries, you can compare the effects of market volatilities on Payment Financial and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Payment Financial with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Payment Financial and Clal Biotechnology.

Diversification Opportunities for Payment Financial and Clal Biotechnology

-0.55

Correlation Coefficient

Payment Financial  Clal Biotechnology

Excellent diversification

The 3 months correlation between Payment and Clal is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Payment Financial Technologies and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Payment Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Payment Financial Technologies are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Payment Financial i.e., Payment Financial and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Payment Financial and Clal Biotechnology

Assuming the 90 days trading horizon Payment Financial Technologies is expected to generate 1.44 times more return on investment than Clal Biotechnology. However, Payment Financial is 1.44 times more volatile than Clal Biotechnology Industries. It trades about 0.13 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.07 per unit of risk. If you would invest  26,379  in Payment Financial Technologies on September 16, 2024 and sell it today you would earn a total of  6,251  from holding Payment Financial Technologies or generate 23.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Payment Financial Technologies  vs.  Clal Biotechnology Industries

Payment Financial

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Payment Financial Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Payment Financial sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Payment Financial and Clal Biotechnology

The main advantage of trading using opposite Payment Financial and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Payment Financial position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.

The idea behind Payment Financial Technologies and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.